Navigation Links
Setting a course for the future of tissue engineering
Date:12/11/2007

New Rochelle, NY, December 11, 2007 The editors of Tissue Engineering asked 24 leaders in the field what critical steps are needed for tissue engineering to achieve broad critical success by the year 2021 and published their findings in the December 2007 issue (Volume 13, Number 12). Tissue Engineering is a peer-reviewed journal published by Mary Ann Liebert, Inc. The paper is available free online.

A survey of the journals editorial boardcomprising leaders in the field of tissue engineering from around the globeyielded a clear picture of the key scientific areas in which researchers need to focus their efforts. Authors Peter Johnson, MD, Co-Editor-in-Chief of Tissue Engineering and President and CEO of Scintellix, LLC, as well as Co-Editor-in-Chief Antonios Mikos, PhD, from Rice University in Houston, TX, John Fisher, PhD, from the University of Maryland, College Park, and John Jansen, DDS, PhD, from Radboud University Nijmegen Medical Center, The Netherlands, present a consensus opinion of these critical paths for development and discuss their implications for the field in a report entitled, "Strategic Directions in Tissue Engineering.

These findings can help scientists in academia and industry, teachers, and funding agencies plan for the future, design research projects and training programs, and set a course to enable the field of tissue engineering to reach its goals and potential for success in clinical medicine.

Our worldwide editorial board was very helpful in sharing critical opinions regarding the future of tissue engineering. We hope that this offering will prove to be useful to all participants in the field says Dr. Johnson.

Leading the list of strategic initiatives is angiogenic control, which defines the ability to provide engineered tissues with an adequate blood supply to nourish their development and survival. Next on the list is stem cell science, which encompasses an understanding of stem cell behavior and how to control their growth, development, and function. Also included among the leading strategic goals identified in the survey is molecular/systems biology, which describes the importance of integrating knowledge about tissues at the cellular and molecular level with a broader view of how they affect and are affected by the organism as a whole.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. Environmental setting of human migrations in the circum-Pacific Region
2. Leading cause of death in preemies might be controlled by resetting a molecular switch
3. Great Plains historical stability vulnerable to future changes
4. Gene may hold key to future cancer hope
5. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
6. NASA technology helps predict and prevent future pandemic outbreaks
7. Sunbathing tree frogs future under a cloud
8. Methane from microbes: a fuel for the future
9. A step toward tissue-engineered heart structures for children
10. Researchers create system to build transplant tissue
11. Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)... , Jan. 25, 2016   Unisys Corporation (NYSE: ... John F. Kennedy (JFK) International Airport, New York City ... (CBP) identify imposters attempting to enter the United States ... to them. pilot testing of the system at ... three terminals at JFK during January 2016. --> pilot ...
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... 2016 Amarantus BioScience Holdings, Inc. ... on developing products for Regenerative Medicine, Neurology and Orphan ... Designation (RPDD) from the US Food and Drug Administration ... was previously granted orphan drug designation (ODD) by the ... BioScience Holdings, Inc. (OTCQB: AMBS), a ...
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced today that Edward Lanphier , Sangamo,s president ... the progress of Sangamo,s ZFP Therapeutic ® development ... at 2:40 pm ET on Thursday, February 11, 2016, ... Healthcare Conference. The conference is being held in ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... commercializing its flagship CytoSorb® blood filter to treat ... around the world, announced that CEO Dr. ... the Source Capital Group,s 2016 Disruptive Growth & ... the company.  Conference Presentation Details: ...
(Date:2/4/2016)... BETHESDA, Md. , Feb. 4, 2016  Spherix ... committed to the fostering and monetization of intellectual property, ... VTech and Uniden in the Northern District of ... are moving forward.  Inter Partes ... the U.S. Patent Office.  The IPR was initiated on ...
Breaking Biology Technology: